In a major development, of the 26 doctors who have died due to COVID-19 in June in Indonesia, at least 10 had already received both the doses of the vaccine developed by Chinese pharmaceutical major Sinovac Biotech Limited, reports Wall Street Journal.
It should also be noted that the vaccination status of the other 16 doctors is still being verified by the Indonesian Medical Association (IMA)'s COVID-19 mitigation group. Thus, the number of doctor deaths despite inoculation with the Chinese vaccine may further rise.
As per the IMA group's latest figures, over five months, at least 20 doctors who were fully inoculated with Sinovac’s vaccine died from COVID-19, accounting for more than a fifth of total fatalities among doctors during that period.
Also, according to the IMA, around 90 per cent of Indonesia's roughly 1,60,000 doctors have all been vaccinated with Sinovac's vaccine.
Meanwhile, epidemiologists have suggested that the deaths need to be investigated to determine whether factors such as poor hospital care or underlying illnesses played a role. Further, the experts also noted that Sinovac vaccine was “probably not as effective a vaccine as most of the other vaccines that are on the market”.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.